Article info
PDFOriginal article
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients
- Correspondence to Professor Gian Franco Zannoni, Department of Pathology, Faculty of Medicine “Agostino Gemelli”, Catholic University of the Sacred Heart, Largo F. Vito 1, Rome 00168, Italy; gfzannoni{at}rm.unicatt.it
Citation
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients
Publication history
- Received March 29, 2016
- Revised April 18, 2016
- Accepted April 18, 2016
- First published May 6, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/